When comparing the expression profiles among subsets, significant differences were observed between NK cells and T cells (p < 0.0001 in both healthy donors and AML patients) and between NK cells and CD56+ NKT-like cells (p = 0.001 in healthy donors and p = 0.03 in AML patients). The gene discussed is NCAM1; the disease is acute myeloid leukemia.